Acute results of balloon angioplasty of native coarctation versus recurrent aortic obstruction are equivalent. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators
BW McCrindle,
TK Jones,
WR Morrow,
DJ Hagler,
TR Lloyd,
S Nouri,
and
LA Latson
Department of Pediatrics, Hospital for Sick Children, University of Toronto, Ontario, Canada.
OBJECTIVES: This study sought to compare the immediate results and risk factors for suboptimal outcomes of percutaneous balloon angioplasty for native versus recurrent aortic obstruction. BACKGROUND: Some cardiology centers have been reluctant to adopt balloon angioplasty for treatment of native aortic coarctation, while advocating balloon angioplasty over an operation for treatment of postsurgical or recurrent aortic obstruction. METHODS: Acute results were analyzed from 970 procedures (422 native and 548 recurrent lesions) performed between 1982 and 1995 in 907 patients from 25 centers. An acute suboptimal outcome was defined as one or more of the following: residual systolic pressure gradient > or = 20 mm Hg, residual proximal to distal systolic pressure ration > or = 1.33 or a major complication (death, aortic transmural tear, stroke). RESULTS: Bal loon angioplasty significantly (p = 0.0001) increased lesion diameter fo r both native (mean [+/= SD] 128 +/= 94%) and recurrent aortic obstruction (97 +/= 87%), with a significantly greater increase in the native group (p = 0.0001). A reduction in systolic pressure gradients was significant in both groups (p = 0.0001), but slightly higher (p = 0.01) for native (-74 +/- 24%) versus recurrent obstruction (-70 +/- 31%). Death associated with angioplasty was reported in 0.7% of patients with native and in 0.7% of patients with recurrent lesions (p = 1.00). An acute suboptimal outcome was noted with angioplasty in 19% of native and in 25% of recurrent lesions (p = 0.04). Significant independent risk factors included higher preangioplasty systolic gradient (odds ratio [OR] 1.39/10-mm Hg increment; 95% confidence interval [CI] 1.28 to 1.50, p = 0.0001), earlier study date (OR 0.92/1-year increment, 95% CI 1.02 to 1.26, p = 0.02) and recurrent obstruction (OR 1.39 vs. native lesions, 95% CI 1.00 to 1.94, p = 0.05). CONCLUSIONS: Acute results and complications of balloon angioplasty of native coarctation appear to be equivalent or slightly superior to those of recurrent aortic obstructions.
This article has been cited by other articles:

|
 |

|
 |
 
J. W. Brown, M. Ruzmetov, M. H. Hoyer, M. D. Rodefeld, and M. W. Turrentine
Recurrent Coarctation: Is Surgical Repair of Recurrent Coarctation of the Aorta Safe and Effective?
Ann. Thorac. Surg.,
December 1, 2009;
88(6):
1923 - 1931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. R. Mohan, S. Danon, D. Levi, D. Connolly, and J. W. Moore
Stent Implantation for Coarctation of the Aorta in Children <30 kg
J. Am. Coll. Cardiol. Intv.,
September 1, 2009;
2(9):
877 - 883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Mishra
Management strategies for interrupted aortic arch with associated anomalies
Eur J Cardiothorac Surg,
April 1, 2009;
35(4):
569 - 576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al.
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
December 2, 2008;
52(23):
e143 - e263.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al.
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation,
December 2, 2008;
118(23):
e714 - e833.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Reich, P. Tax, H. Bartakova, V. Tomek, J. Gilik, J. Lisy, J. Radvansky, T. Matejka, T. Tlaskal, I. Svobodova, et al.
Long-term (up to 20 years) results of percutaneous balloon angioplasty of recurrent aortic coarctation without use of stents
Eur. Heart J.,
August 2, 2008;
29(16):
2042 - 2048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bedard, D. F. Shore, and M. A. Gatzoulis
Adult congenital heart disease: a 2008 overview
Br. Med. Bull.,
March 1, 2008;
85(1):
151 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Aboulhosn and J. S. Child
Left Ventricular Outflow Obstruction: Subaortic Stenosis, Bicuspid Aortic Valve, Supravalvar Aortic Stenosis, and Coarctation of the Aorta
Circulation,
November 28, 2006;
114(22):
2412 - 2422.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Eicken, U. Pensl, W. Sebening, A. Hager, T. Genz, C. Schreiber, D. Lang, H. Kaemmerer, R. Busch, and J. Hess
The fate of systemic blood pressure in patients after effectively stented coarctation
Eur. Heart J.,
May 1, 2006;
27(9):
1100 - 1105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tzifa, P. Ewert, G. Brzezinska-Rajszys, B. Peters, M. Zubrzycka, E. Rosenthal, F. Berger, and S. A. Qureshi
Covered Cheatham-Platinum Stents for Aortic Coarctation: Early and Intermediate-Term Results
J. Am. Coll. Cardiol.,
April 4, 2006;
47(7):
1457 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. McCrindle, C. I. Tchervenkov, I. E. Konstantinov, W. G. Williams, R. A. Neirotti, M. L. Jacobs, E. H. Blackstone, and For the members of the Congenital Heart Surgeons S
Risk factors associated with mortality and interventions in 472 neonates with interrupted aortic arch: A Congenital Heart Surgeons Society study
J. Thorac. Cardiovasc. Surg.,
February 1, 2005;
129(2):
343 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. DiBardino, J. S. Heinle, G. C. Kung, G. T. Leonard Jr, E. D. McKenzie, J. T. Su, and C. D. Fraser Jr
Anatomic reconstruction for recurrent aortic obstruction in infants and children
Ann. Thorac. Surg.,
September 1, 2004;
78(3):
926 - 932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Hamdan, S. Maheshwari, J. T. Fahey, and W. E. Hellenbrand
Endovascular stents for coarctation of the aorta: initial results and intermediate-term follow-up
J. Am. Coll. Cardiol.,
November 1, 2001;
38(5):
1518 - 1523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Rosenthal
Stent implantation for aortic coarctation: the treatment of choice in adults?
J. Am. Coll. Cardiol.,
November 1, 2001;
38(5):
1524 - 1527.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Magee, C. I. Blauth, and S. A. Qureshi
Interventional and surgical management of aortic stenosis and coarctation
Ann. Thorac. Surg.,
February 1, 2001;
71(2):
713 - 715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L GIBBS
Treatment options for coarctation of the aorta
Heart,
July 1, 2000;
84(1):
11 - 13.
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Maheshwari, E. Bruckheimer, J. T. Fahey, and W. E. Hellenbrand
Balloon angioplasty of postsurgical recoarctation in infants: The risk of restenosis and long-term follow-up
J. Am. Coll. Cardiol.,
January 1, 2000;
35(1):
209 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Poirier, G. S. Van Arsdell, M. Brindle, G. K. Thyagarajan, J. G. Coles, M. D. Black, R. M. Freedom, and W. G. Williams
Surgical treatment of aortic arch hypoplasia in infants and children with biventricular hearts
Ann. Thorac. Surg.,
December 1, 1999;
68(6):
2293 - 2297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A G Magee, G Brzezinska-Rajszys, S A Qureshi, E Rosenthal, M Zubrzycka, J Ksiazyk, and M Tynan
Stent implantation for aortic coarctation and recoarctation
Heart,
November 1, 1999;
82(5):
600 - 606.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. G. Sakopoulos, T. L. Hahn, M. Turrentine, and J. W. Brown
Recurrent aortic coarctation: Is surgical repair still the gold standard?
J. Thorac. Cardiovasc. Surg.,
October 1, 1998;
116(4):
560 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Shirali, C. E. Cephus, M. A. Kuhn, K. K. Ogata, L. K. Vander Dussen, R. E. Chinnock, N. F. Mulla, J. K. Johnston, L. L. Bailey, S. R. Gundry, et al.
Posttransplant recoarctation of the aorta: a twelve year experience
J. Am. Coll. Cardiol.,
August 1, 1998;
32(2):
509 - 514.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|